Vera Therapeutics, Inc. (VERA)
26.97
-1.13
(-4.02%)
USD |
NASDAQ |
Nov 16, 16:00
26.97
0.00 (0.00%)
After-Hours: 19:00
Vera Therapeutics Total Assets (Quarterly) : 465.75M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 465.75M |
| June 30, 2026 | 532.98M |
| March 31, 2026 | 621.74M |
| December 31, 2025 | 735.30M |
| September 30, 2025 | 517.50M |
| June 30, 2025 | 578.53M |
| March 31, 2025 | 610.17M |
| December 31, 2024 | 656.47M |
| September 30, 2024 | 368.56M |
| June 30, 2024 | 397.29M |
| March 31, 2024 | 419.36M |
| December 31, 2023 | 175.55M |
| Date | Value |
|---|---|
| September 30, 2023 | 175.62M |
| June 30, 2023 | 195.18M |
| March 31, 2023 | 209.60M |
| December 31, 2022 | 131.44M |
| September 30, 2022 | 131.37M |
| June 30, 2022 | 148.78M |
| March 31, 2022 | 164.97M |
| December 31, 2021 | 83.75M |
| September 30, 2021 | 91.17M |
| June 30, 2021 | 97.65M |
| March 31, 2021 | 51.82M |
| December 31, 2020 | 54.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.269B |
| Sarepta Therapeutics, Inc. | 3.166B |
| Twist Bioscience Corp. | 1.122B |
| Oncolytics Biotech, Inc. | 5.832M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.57M |
| Shareholders Equity (Quarterly) | 333.19M |
| Debt to Equity Ratio | 0.2264 |
| Current Ratio | 7.440 |
| Net Debt Paydown Yield | 0.02% |